Incorporated in Delaware under the name Advanced Medicine, Inc.
Changed its name to Theravance, Inc.
Innoviva / GSK collaboration agreement signed
Breo launched in the US
Anoro launched in the US
Spun-off research and development operations
Rebranded to Innoviva, Inc.
Trelegy launched in the US.
Armata* and Innoviva announced strategic investment
Entasis and Innoviva announced private placement
Innoviva announced strategic repurchase of GSK’s equity stake
Announced acquisition of Entasis Therapeutics
Announced acquisition of La Jolla Pharmaceutical Company
Sold 15% stake in Theravance Respiratory Company**
Announced integration of Entasis and La Jolla into Innoviva Specialty Therapeutics
FDA approval of XACDURO®